Henry J Fuchs - Net Worth and Insider Trading
Henry J Fuchs Net Worth
The estimated net worth of Henry J Fuchs is at least $14 Million dollars as of 2024-11-13. Henry J Fuchs is the President, Worldwide R&D of Biomarin Pharmaceutical Inc and owns about 212,117 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $14 Million. Henry J Fuchs is also the Director of Mirati Therapeutics Inc and owns about 6,021 shares of Mirati Therapeutics Inc (MRTX) stock worth over $353,433. Details can be seen in Henry J Fuchs's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Henry J Fuchs has not made any transactions after 2024-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Henry J Fuchs
Henry J Fuchs Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Henry J Fuchs owns 2 companies in total, including Mirati Therapeutics Inc (MRTX) , and Biomarin Pharmaceutical Inc (BMRN) .
Click here to see the complete history of Henry J Fuchs’s form 4 insider trades.
Insider Ownership Summary of Henry J Fuchs
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRTX | Mirati Therapeutics Inc | 2022-02-11 | director |
| BMRN | Biomarin Pharmaceutical Inc | 2024-03-05 | Chief Medical Officer |
Henry J Fuchs Latest Holdings Summary
Henry J Fuchs currently owns a total of 2 stocks. Among these stocks, Henry J Fuchs owns 212,117 shares of Biomarin Pharmaceutical Inc (BMRN) as of March 5, 2024, with a value of $14 Million and a weighting of 97.54%. Henry J Fuchs also owns 6,021 shares of Mirati Therapeutics Inc (MRTX) as of February 11, 2022, with a value of $353,433 and a weighting of 2.46%.
Latest Holdings of Henry J Fuchs
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2024-03-05 | 212,117 | 66.12 | 14,025,176 |
| MRTX | Mirati Therapeutics Inc | 2022-02-11 | 6,021 | 58.70 | 353,433 |
Holding Weightings of Henry J Fuchs
Henry J Fuchs Form 4 Trading Tracker
According to the SEC Form 4 filings, Henry J Fuchs has made a total of 6 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 35,341 shares on March 5, 2024, which brought Henry J Fuchs around $3 Million.
According to the SEC Form 4 filings, Henry J Fuchs has made a total of 3 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 11,000 shares on February 11, 2022, which brought Henry J Fuchs around $1 Million.
Insider Trading History of Henry J Fuchs
- 1
Henry J Fuchs Trading Performance
Henry J Fuchs Ownership Network
Ownership Network List of Henry J Fuchs
Ownership Network Relation of Henry J Fuchs
Henry J Fuchs Owned Company Details
What does Mirati Therapeutics Inc do?
Who are the key executives at Mirati Therapeutics Inc?
Henry J Fuchs is the director of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include EVP & Chief Commercial Officer Benjamin Hickey , Sr. Vice President & Chief Scie Jamie Christensen , and Interim CFO Aaron Ondrey .
Mirati Therapeutics Inc (MRTX) Insider Trades Summary
Over the past 18 months, Henry J Fuchs made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 8,522 shares made by Jamie Christensen , a net sale of 5,907 shares made by Benjamin Hickey , and a net purchase of 2,517,946 shares made by Boxer Capital, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,076 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,509,661 shares.
Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirati Therapeutics Inc Insider Transactions
Henry J Fuchs Mailing Address
Above is the net worth, insider trading, and ownership report for Henry J Fuchs. You might contact Henry J Fuchs via mailing address: C/o Biomarin Pharmaceutical Inc., 105 Digital Drive, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
